Researchers from the Memorial Sloan Kettering Cancer Center say they have discovered that the knee joint communicates with developing bones in mice, a process that controls bone growth during early development and after injury.

The scientists, who published their findings (“Altered Paracrine Signaling from the Injured Knee Joint Impairs Postnatal Long Bone Growth”) in eLife, concluded that bone growth is controlled not only from within the bone itself, but by neighboring cells in nearby joints. These cells “talk” to developing bone cells to help them grow and mature. Once more is learned about how these communication channels function, this knowledge could result in improved therapies for correcting bone growth defects.

 “We devised a genetic mouse model to study extrinsic long bone growth modulation, in which injury is specifically induced in the left hindlimb, such that the right hindlimb serves as an internal control. Remarkably, when only mesenchyme cells surrounding postnatal GPs [growth plates] were killed, left bone growth was nevertheless reduced,” write the investigators.

“GP signaling was impaired by altered paracrine signals from the knee joint, including activation of the injury response and, in neonates, dampened IGF1 [insulin-like growth factor 1] production. Importantly, only the combined prevention of both responses rescued neonatal growth. Thus, we identified signals from the knee joint that modulate bone growth and could underlie establishment of body proportions.”

“The identification of local signals coming from elsewhere, and their contribution to the growth plate is only just beginning to emerge,” explains lead author Alberto Roselló-Díez, Ph.D., postdoctoral research fellow at Sloan Kettering. “A major obstacle is the lack of models where only cells outside of the growth plate can be altered, so we developed a mouse model to study the contribution of individual communication pathways outside the plate.”

The team first tested whether damage to cells surrounding the growth plate would affect bone growth in the left leg of mice. The growth plate itself was left intact, as was the right leg for comparison to the left.

The group observed that damaging these surrounding tissues impaired growth plate function and stunted bone growth.

Further investigation revealed that loss of surrounding cells causes multiple changes in cell communication, which impairs bone cells' ability to multiply and increase in size.

One pathway–the insulin-like signaling pathway– was much less active in the left knee joint of the mice. A closer look showed that immune cells were suppressing this pathway, leaving the growth plate without this vital signal. However, replenishing the signal didn't completely reverse the effect. This means that insulin-like signaling is only one of several key pathways.

The team next looked at whether classic damage response signals were activated in the knee joint after injury. They found similar patterns in the left mouse leg to those seen in osteoarthritis, not only in the knee structures but also in the cartilage that wraps the bones' ends, suggesting that the injury response is a further mechanism that triggers altered signaling from the knee joint to the growth plate.

At later stages of development, the insulin-like pathway was no longer active in the knee joint of either limb, showing that bone growth eventually becomes independent of this external influence.

According to the researchers, this observation reinforces the concept that local signals from outside the growth plate are important in establishing body proportions early on in development.

“We have identified two components of the knee joint that control bone growth, at least following injury, and we've shown that signals from these components influence distinct growth plate signaling pathways and lead to reduced bone growth,” notes Alexandra Joyner, Ph.D., senior author and developmental biologist at Sloan Kettering. “Further studies are needed to confirm and expand the repertoire of local regulators of bone growth, adding valuable insights to evolutionary studies and providing avenues for therapies that can correct long bone growth defects.”

Previous articlePCR Optimization 2.0
Next articleUC and Partners File Brief in Appeal of PTAB CRISPR Decision